REG - Inchcape PLC - Directorate Change

InchcapeAnnouncement

19/04/2021 08:00

RNS Number : 7783V
  
Inchcape PLC
  
19 April 2021
  
 

INCHCAPE PLC
 
Directorate change
 
Inchcape plc announces that Nayantara Bali will be appointed as a Non-Executive Director from the conclusion of the Annual General Meeting on 27 May 2021, and will join the Nomination and CSR Committees upon appointment.
 
Since 2016, Nayantara has been the co-owner and director of ANV Consulting, a boutique Management Consultancy specializing in leveraging data analytics, Prior to this, Nayantara was with Procter & Gamble for over 28 years holding several senior regional and global positions based in Singapore, Thailand, and India.
 
Nayantara is also an independent director of Torrent Pharma, a leading pharmaceuticals company in India, and a non-executive director of Starhub, a major Singapore telecoms company. 
 
Chairman, Nigel Stein said:
"We are delighted to welcome Nayantara to the Inchcape Board. Her wide experience of data-driven marketing to consumers in Asia, combined with her previous experience as a non-executive director, make her a valuable addition to our Board. She is based in Singapore, home to our Asian operations and in itself an important market for Inchcape.
 
There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 relating to the appointment to the Board of Nayantara Bali.
 
 
Ends
Group Communications, Inchcape plc

+44 (0) 20 7546 0022
 
Notes to editors 
About Inchcape:
Inchcape plc is the leading independent multi-brand Automotive Distributor and Retailer, operating in 34 markets with a portfolio of the world's leading car brands. Inchcape has diversified multi-channel revenue streams including sale of new and used vehicles, parts, service, finance and insurance. The Group has been listed on the London Stock Exchange since 1958, is headquartered in London and employs around 15,000 people. www.inchcape.com
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
BOAIFMJTMTMBBRB